My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Fulgent Genetics, Inc.

< Previous 1 2 Next >
Fulgent Genetics to Announce Fourth Quarter and Full Year 2022 Financial Results on Tuesday, February 28, 2023
From Fulgent Genetics, Inc.
Via Business Wire
Tickers FLGT
Fulgent Expands Board of Directors with Addition of Reggie Groves
From Fulgent Genetics, Inc.
Via Business Wire
Tickers FLGT
Fulgent Genetics to Participate in Piper Sandler’s 34th Annual Healthcare Conference
From Fulgent Genetics, Inc.
Via Business Wire
Tickers FLGT
Fulgent Genetics Acquires Fulgent Pharma, Creating a New Paradigm in Precision Medicine for The Company
From Fulgent Genetics, Inc.
Via Business Wire
Tickers FLGT
Fulgent Genetics Reports Third Quarter 2022 Financial Results
From Fulgent Genetics, Inc.
Via Business Wire
Tickers FLGT
Fulgent Genetics to Participate in Credit Suisse’s 31st Annual Healthcare Conference
From Fulgent Genetics, Inc.
Via Business Wire
Tickers FLGT
Fulgent Genetics to Announce Third Quarter 2022 Financial Results on Monday November 7, 2022
From Fulgent Genetics, Inc.
Via Business Wire
Tickers FLGT
Fulgent Genetics Reports Second Quarter 2022 Financial Results
From Fulgent Genetics, Inc.
Via Business Wire
Tickers FLGT
Fulgent Genetics Welcomes Dr. Michael Nohaile and Dr. Leonard Post to Board of Directors
From Fulgent Genetics, Inc.
Via Business Wire
Tickers FLGT
Fulgent Genetics Announces Launch of PCR Based Test to Detect Monkeypox
From Fulgent Genetics, Inc.
Via Business Wire
Tickers FLGT
Fulgent Genetics to Announce Second Quarter 2022 Financial Results on Thursday, August 4, 2022
From Fulgent Genetics, Inc.
Via Business Wire
Tickers FLGT
Fulgent Genetics Reports First Quarter 2022 Financial Results
From Fulgent Genetics, Inc.
Via Business Wire
Tickers FLGT
Fulgent Genetics Announces Promotions and Leadership Updates
From Fulgent Genetics, Inc.
Via Business Wire
Tickers FLGT
Fulgent Genetics Announces Opening of New State-of-the-Art Oncology Laboratory in El Monte, California
From Fulgent Genetics, Inc.
Via Business Wire
Tickers FLGT
Fulgent Genetics Agrees to Acquire Inform Diagnostics and Provides Preliminary First Quarter Revenue Results
From Fulgent Genetics, Inc.
Via Business Wire
Tickers FLGT
Fulgent Genetics to Announce First Quarter 2022 Financial Results on Tuesday, May 3, 2022
From Fulgent Genetics, Inc.
Via Business Wire
Tickers FLGT
Fulgent Genetics Announces Strategic Investment in Spatial Genomics
From Fulgent Genetics, Inc.
Via Business Wire
Tickers FLGT
Fulgent Genetics Reports Fourth Quarter and Full Year 2021 Financial Results
From Fulgent Genetics, Inc.
Via Business Wire
Tickers FLGT
Fulgent Genetics to Announce Fourth Quarter and Full Year 2021 Financial Results on Wednesday February 23, 2022
From Fulgent Genetics, Inc.
Via Business Wire
Tickers FLGT
HelioLiver™, an Innovative Liquid Biopsy Test for the Early Detection of Liver Cancer, is Now Commercially Available
From Fulgent Genetics, Inc.
Via Business Wire
Tickers FLGT
Fulgent Genetics Confirms Ability to Detect Omicron Variant with RT-PCR Tests for COVID-19
From Fulgent Genetics, Inc.
Via Business Wire
Tickers FLGT
Fulgent Genetics Reports Third Quarter Financial Results
From Fulgent Genetics, Inc.
Via Business Wire
Tickers FLGT
Representatives of Fulgent Genetics to Participate in Upcoming Virtual Conferences
From Fulgent Genetics, Inc.
Via Business Wire
Tickers FLGT
Fulgent Genetics Launches At-Home Neutralizing Antibody Test for COVID-19
From Fulgent Genetics, Inc.
Via Business Wire
Tickers FLGT
Fulgent Genetics to Announce Third Quarter 2021 Financial Results on Tuesday November 9, 2021
From Fulgent Genetics, Inc.
Via Business Wire
Tickers FLGT
Fulgent Genetics to Partner with Houston Health Department and Houston-Area Public Schools on Back-to-School COVID-19 Testing Program
From Fulgent Genetics, Inc.
Via Business Wire
Tickers FLGT
Fulgent Genetics Reports Second Quarter Financial Results
From Fulgent Genetics, Inc.
Via Business Wire
Tickers FLGT
Fulgent Genetics and Helio Health Announce Strategic Partnership to Commercialize Early Cancer Detection Tests
From Fulgent Genetics, Inc.
Via Business Wire
Tickers FLGT
Fulgent Genetics Announces Acquisition of CSI Laboratories
From Fulgent Genetics, Inc.
Via Business Wire
Tickers FLGT
CORRECTING and REPLACING Fulgent Genetics to Announce Second Quarter 2021 Financial Results on Monday, August 9, 2021
From Fulgent Genetics, Inc.
Via Business Wire
Tickers FLGT
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.